Key facts
- medZERO’s last known valuation is $16.0M (Mar 2021).
- It has raised $12.3M across 2 recorded rounds; the latest was Seed Round ($1.5M) in Oct 2024.
- Notable investors include Village Global, True Ventures, Grand Ventures, Blue Hour Ventures, Capital Eleven — 7 tracked in total.
- medZERO has filed 5 Form Ds with the SEC since 2021, most recently May 2026 ($3.9M sold to 25 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for medZERO
Funding rounds
2 roundsAbout medZERO
Developer of a healthcare financing platform designed to offer employees access to interest-free, fee-free funds to cover out-of-pocket medical expenses. The company platform helps employers provide a valuable benefit that boosts employee satisfaction and retention while addressing the growing concern over medical debt and financial insecurity due to healthcare costs, enabling employers to provide financial peace of mind to their workforce.
- Sector
- Financial Services
- HQ
- Portland, OR, United States
- Employees
- 12
- Website
- medzero.com/
- Ownership
- Privately Held (backing)
medZERO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in medZERO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on medZERO in its N-PORT filings yet. We sweep new filings monthly.